Palau vs Switzerland: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Palau
- Switzerland
How they compare
Switzerland currently reports 23.1% against 23.0% in Palau, a difference of 0.1%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Palau ahead.
Palau ranks 61st and Switzerland ranks 59th of 166 countries.
Across the 3 decades both report, Palau averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Palau | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 29.0% | 0.5% | Palau |
| 2010s | 26.2% | 26.2% | 0.0% | — |
| 2020s | 23.4% | 23.6% | 0.1% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Palau or Switzerland?
- Switzerland, at 23.1% against 23.0% in Palau as of 2024.
- What is the difference in prevalence of current tobacco use between Palau and Switzerland?
- 0.1%, with Switzerland ahead.
- How many years of comparable data are there for Palau and Switzerland?
- 9 years are reported by both, from 2000 to 2024.
- How do Palau and Switzerland rank globally for prevalence of current tobacco use?
- Palau ranks 61st and Switzerland ranks 59th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.